|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
INSM | SHAROKY MELVIN MD | Director | May 15 | Buy | 19.29 | 10,000 | 192,900 | 298,615 | May 17 04:06 PM |
INSM | SHAROKY MELVIN MD | Director | May 15 | Buy | 19.29 | 10,000 | 192,900 | 10,000 | May 17 04:06 PM |
INSM | SHAROKY MELVIN MD | Director | Oct 31 | Buy | 17.53 | 20,000 | 350,600 | 281,021 | Nov 02 04:23 PM |
INSM | SHAROKY MELVIN MD | Director | Nov 01 | Buy | 17.70 | 10,000 | 177,000 | 15,900 | Nov 02 04:23 PM |
INSM | SHAROKY MELVIN MD | Director | May 11 | Buy | 17.20 | 20,000 | 344,000 | 262,621 | May 13 06:15 PM |
INSM | SHAROKY MELVIN MD | Director | Nov 19 | Sale | 39.48 | 4,000 | 157,920 | 7,714 | Nov 20 04:09 PM |
INSM | SHAROKY MELVIN MD | Director | Sep 14 | Sale | 30.70 | 100 | 3,070 | 19,900 | Sep 16 06:56 PM |
INSM | SHAROKY MELVIN MD | Director | Sep 15 | Sale | 31.03 | 9,900 | 307,197 | 236,890 | Sep 16 06:56 PM |
INSM | SHAROKY MELVIN MD | Director | Sep 15 | Sale | 30.33 | 10,000 | 303,300 | 9,900 | Sep 16 06:56 PM |
INSM | SHAROKY MELVIN MD | Director | Nov 09 | Buy | 16.34 | 11,205 | 183,102 | 11,205 | Nov 13 04:03 PM |
INSM | SHAROKY MELVIN MD | Director | Nov 12 | Buy | 15.59 | 8,795 | 137,110 | 20,000 | Nov 13 04:03 PM |
INSM | SHAROKY MELVIN MD | Director | Sep 05 | Sale | 28.91 | 25,000 | 722,782 | 250,728 | Sep 07 05:41 PM |
INSM | SHAROKY MELVIN MD | Director | Sep 06 | Sale | 25.84 | 25,000 | 645,915 | 225,728 | Sep 07 05:41 PM |
INSM | SHAROKY MELVIN MD | Director | Mar 24 | Option Exercise | 6.50 | 1,750 | 11,375 | 268,441 | Mar 26 04:04 PM |
INSM | SHAROKY MELVIN MD | Director | Apr 14 | Option Exercise | 8.30 | 1,750 | 14,525 | 171,580 | Apr 16 04:20 PM |
INSM | SHAROKY MELVIN MD | Director | Jan 10 | Buy | 0.80 | 70,000 | 56,256 | 392,670 | Jan 14 04:31 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite